Cooling the Future with Liquid Ventilation
Dive into Favorable Environments’ latest: Orixha CEO Fabrice Paublant unveils liquid ventilation tech poised to transform post-cardiac arrest care, cooling patients to 33°C in under 20 minutes to curb $1.5B annual U.S. organ damage costs. With MIT-honed expertise, Paublant emphasizes lean funding and collective intelligence for medtech scale-up. Explore ROI potential for job-creating biotech hubs.
Stream the episode and connect with USD Discovery District for policy-aligned partnerships fostering regional growth.